The last few weeks have seen a number of announcements related to nano and sustainable materials testing, regulation and commercialization. These are some of the top stories that caught our eyes:

A new paper summarizes progress on safer and sustainable by design (SSbD) approaches for nano and advanced materials and highlights recent work to meet the challenges to their practical implementation: including progress on projects that Vireo is carrying out as a DIAGONAL Project Partner.

In a landmark decision, the EU Court of Justice ruled that 2017 decisions on carcinogenicity for TiO2  did not rely on valid evidence. The animal studies used were not relevant to humans and they failed to show an intrinsic cause of cancer. The court decision has implications for the EU ban of TiO2 in food.

The U.S. FDA NanoDay Symposium 2022, on October 11, 2022, will include an overview and discussion of their Guidance for Industry on drug products, including biological products, which contain nanomaterials.

The annual UMaine CNM (cellulose nanomaterial) forum starts today, Wednesday, August 24, and continues on Thursday, August 25.